摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[adamantan-1-yl]-4-{2-[(1-{4-[({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)carbamoyl]phenyl}piperidin-4-ylidene)methyl]phenyl}-N,N-diphenyl-1H-pyrazole-3-carboxamide | 1335147-85-7

中文名称
——
中文别名
——
英文名称
1-[adamantan-1-yl]-4-{2-[(1-{4-[({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)carbamoyl]phenyl}piperidin-4-ylidene)methyl]phenyl}-N,N-diphenyl-1H-pyrazole-3-carboxamide
英文别名
1-(1-adamantyl)-4-[2-[[1-[4-[[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonylcarbamoyl]phenyl]piperidin-4-ylidene]methyl]phenyl]-N,N-diphenylpyrazole-3-carboxamide
1-[adamantan-1-yl]-4-{2-[(1-{4-[({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)carbamoyl]phenyl}piperidin-4-ylidene)methyl]phenyl}-N,N-diphenyl-1H-pyrazole-3-carboxamide化学式
CAS
1335147-85-7
化学式
C57H59N7O7S
mdl
——
分子量
986.204
InChiKey
WFWHTERZBBVJCE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    11.1
  • 重原子数:
    72
  • 可旋转键数:
    13
  • 环数:
    12.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    180
  • 氢给体数:
    2
  • 氢受体数:
    10

文献信息

  • APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    申请人:Ding Hong
    公开号:US20110237553A1
    公开(公告)日:2011-09-29
    Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    揭示了抑制抗凋亡Bcl-2蛋白活性的化合物,包含这些化合物的组合物以及治疗在其中表达抗凋亡Bcl-2蛋白的疾病的方法。
  • Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
    申请人:Abbvie Inc.
    公开号:EP2757105A1
    公开(公告)日:2014-07-23
    This invention pertains to compounds, or therapeutically acceptable salts thereof, which inhibit the activity of Bcl-2 anti-apoptotic proteins, pharmaceutical compositions containing the compounds, and compounds and compositions for use in treating diseases during which anti-apoptotic Bcl-2 proteins are expressed.
    本发明涉及抑制 Bcl-2 抗凋亡蛋白活性的化合物或其治疗上可接受的盐类、含有这些化合物的药物组合物,以及用于治疗表达抗凋亡 Bcl-2 蛋白的疾病的化合物和组合物。
  • US8188077B2
    申请人:——
    公开号:US8188077B2
    公开(公告)日:2012-05-29
  • US8343967B2
    申请人:——
    公开号:US8343967B2
    公开(公告)日:2013-01-01
  • [EN] APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES<br/>[FR] AGENTS INDUISANT L'APOPTOSE POUR LE TRAITEMENT DU CANCER ET DE MALADIES IMMUNES ET AUTO-IMMUNES
    申请人:ABBOTT LAB
    公开号:WO2011119345A2
    公开(公告)日:2011-09-29
    Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti apoptotic Bcl-2 protein.
查看更多